Skip to content
GW-501516

Structure via PubChem · Public domain (PubChem)

EntityQ5515069· pop 10· linked from 190 articles

Also known as Cardarine, GSK-516, GW 501516, GW1516, Endurobol, GW-516, GW 1516, GW-1516

GW501516 (also known as GW-501,516, GW1516, GSK-516, cardarine, and on the black market as endurobol) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s. It entered into clinical development as a drug candidate for metabolic and cardiovascular diseases, but was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.

Chemical data

Formula
C21H18F3NO3S2
Molecular weight
453.5 g/mol
IUPAC name
2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid
SMILES
CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O
InChIKey
YDBLKRPLXZNVNB-UHFFFAOYSA-N
XLogP
5.9
Polar surface area
113 Ų
H-bond donors
1
H-bond acceptors
9
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
Disorder of lipid metabolism

via ChEMBL · EBI

Wikidata facts

Mass
453.06802
Show 3 more facts
chemical formula
C₂₁H₁₈F₃NO₃S₂
canonical SMILES
CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O
Commons category
GW501516
Sources (2)

via Wikidata · CC0

~8 min read

Encyclopedic overview

5 sections
Contents
  • History
  • Performance-enhancing drug
  • Mechanism of action
  • See also
  • References

{{Drugbox | Verifiedfields = changed | verifiedrevid = 458657924 | IUPAC_name = {2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid | image = GW501,516.svg | image_class = skin-invert-image | width = 270

| tradename = | legal_AU = Scheduled as illegal from June 2018 | legal_US = unscheduled | legal_UK = unscheduled | routes_of_administration = By mouth | pregnancy_category = N/A

Excerpted from Wikipedia’s “GW-501516” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0